Company
Exact Sciences UK, LTD.
Exact Sciences UK, LTD. is an active UK company (number 07484560), incorporated 2011, with 3 current directors including James Russell Wenner and Bradley Jay Slater. Source: Companies House, updated 11th October 2026.
Official record Companies House · updated 11th October 2026 · Sources
Network
The large node is Exact Sciences UK, LTD.. Red nodes are organisations, white nodes are people. Sign in free to explore further.
Who leads it
Previous officers 19
- Katherine Ava Miller Hottmann 2025-2026 View profile
- Matthew Bull 2024-2025 View profile
- StéPhane Marcel Pierre Petit 2022-2023 View profile
- Antonio La Regina 2022-2024 View profile
- James Michael John Herriott 2022-2026 View profile
- Kyle Andrew Stacey 2019-2025 View profile
- Jeffrey Thomas Elliott 2019-2024 View profile
- Kevin Thomas Conroy 2019-2024 View profile
- David Scott Coward 2019-2022 View profile
- Jason William Radford 2017-2019 View profile
- Jonathan Andrew Kindred Truelove 2017-2024 View profile
- Brian Patrick Hogan 2017-2017 View profile
- Stephen John Ogram 2016-2023 View profile
- Andrea Benson Pithers 2015-2016 View profile
- Gordon Bradley Cole 2014-2017 View profile
- Kim Ellen Mceachron 2014-2017 View profile
- Inc. Genomic Health 2011-2016 View profile
- Kathy Hibbs 2011-2014 View profile
- Dean Lawrence Schorno 2011-2014 View profile
Directors and secretaries as filed at Companies House.
Do you help lead this organisation? Set up its network · How it works
Public contracts won
3 contracts · £780,000 totalFrom Contracts Finder and Find a Tender, the UK Government's public procurement notices, under the Open Government Licence v3.0. Matched to this organisation by company number, charity number or exact name and postcode; every figure links to its source notice.
-
Oncotype DX Breast Cancer Testing
Oncotype DX is a validated genomic assay recommended by NICE (DG34) for guiding chemotherapy decisions in specific cohorts of early breast cancer. It provides a Recurrence Score that stratifies patients into groups where chemotherapy is b…
-
Exact Sciences - Oncotype DX Breast Recurrence Score tests
Call off contract from framework.
-
Oncotype DX Breast recurrence score test
Breast Cancer Recurrence Score Test contract ref PTH-22-21-11621 Contract extension taken 1st July 2025
About
- Incorporated
- 06/01/2011
Board analysis
Board DNA
How this board is put together, from the Companies House officer record and Charity Commission trustee records - deterministic, no AI.iBoard compositionCounted from the dated Companies House officer record: the current directors only, past directors excluded.
3 directors on the board
- James Russell Wenner Director · appointed 2026
- Andrew James Roberts Director · appointed 2025
- Bradley Jay Slater Director · appointed 2026
First-time vs portfolio directors
Portfolio (3)
- James Russell Wenner Director · appointed 2026
- Andrew James Roberts Director · appointed 2025
- Bradley Jay Slater Director · appointed 2026
Left in the last 12 months
- Katherine Ava Miller Hottmann Director · appointed 2025 · resigned 2026
- James Michael John Herriott Director · appointed 2022 · resigned 2026
Where else this board sits iWhere else this board sitsThe charitable fields these directors govern in elsewhere, by Charity Commission classification. Excludes this company and any charity it is the legal face of.
The sectors these directors govern in elsewhere. This company, and any charity it is the legal face of, are excluded - counting them would just tell you what you are already looking at.
Sources
Official record from Companies House. Governance Register calculates the connections.
Record details
- Company number
- 07484560
- Status
- Active
- Type
- Private Limited Company
- Edition
- Register edition compiled 11th October 2026
- Labels
- Official record from Companies House · Calculated derived by Governance Register.
Contains public sector information licensed under the Open Government Licence v3.0. Report an issue · How we handle data